D-Hormone Derivatives for the Treatment of Osteoporosis: From Alfacalcidol to Eldecalcitol

E-ISSN： 1875-5607|9|12|1416-1422

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.9, Iss.12, 2009-01, pp. : 1416-1422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eldecalcitol: newly developed active vitamin D₃ analog for the treatment of osteoporosis

By Hagino Hiroshi

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 817-825

Informa Healthcare

Access to resources Recommend Favorite

Eldecalcitol: A Review of its Use in the Treatment of Osteoporosis

By Sanford Mark McCormack Paul L.

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1755-1770

Adis International

Access to resources Recommend Favorite

Spotlight on Eldecalcitol in Osteoporosis†

By Sanford Mark McCormack Paul L.

Drugs & Aging, Vol. 29, Iss. 1, 2012-01 ,pp. : 69-71

Adis International

Access to resources Recommend Favorite

Parathyroid Hormone An Anabolic Treatment for Osteoporosis.

Current Pharmaceutical Design, Vol. 7, Iss. 8, 2001-05 ,pp. : 671-687

Bentham Science Publishers

Access to resources Recommend Favorite

Parathyroid hormone (1-34): a major advance in the treatment of osteoporosis?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 11, 2001-11 ,pp. : 1919-1920

Informa Healthcare

Access to resources Recommend Favorite